Work

Defining “Innovativeness” in Drug Development: A Systematic Review

Year: 2013

Type: review

Study design: Systematic Review

Source: Clinical Pharmacology & Therapeutics

DOI: 10.1038/clpt.2013.115

Authors: A S Kesselheim, B Wang, J Avorn

Institutions: Brigham and Women's Hospital, Harvard University

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Robert Wood Johnson Foundation, National Institutes of Health, Agency for Healthcare Research and Quality

Award: G4022652037

OpenAlex ID: W2036062389

FWCI: 1.87

Cites: 56

Cited by: 59

Related to: 10